Home533573 • BOM
add
Alembic Pharmaceuticals Ltd
Previous close
₹801.80
Day range
₹780.20 - ₹810.55
Year range
₹725.60 - ₹1,107.80
Market cap
157.40B INR
Avg Volume
3.77K
P/E ratio
24.99
Dividend yield
1.37%
Primary exchange
NSE
In the news
Financials
Income Statement
Revenue
Net income
| (INR) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 18.76B | 10.84% |
Operating expense | 11.34B | 6.67% |
Net income | 1.33B | -3.94% |
Net profit margin | 7.09 | -13.33% |
Earnings per share | 8.51 | 21.46% |
EBITDA | 2.78B | 9.74% |
Effective tax rate | 18.29% | — |
Balance Sheet
Total assets
Total liabilities
| (INR) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 1.43B | 10.92% |
Total assets | — | — |
Total liabilities | — | — |
Total equity | 53.16B | — |
Shares outstanding | 196.70M | — |
Price to book | 2.96 | — |
Return on assets | — | — |
Return on capital | 7.84% | — |
Cash Flow
Net change in cash
| (INR) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | 1.33B | -3.94% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Founded
1907
Employees
16,571
